Early B-cell Factor1 (Ebf1) promotes early osteoblast differentiation but suppresses osteoblast function

Area of Science:

• * Molecular biology
• * Cell biology
• * Bone biology

Background:

• * Early B cell factor 1 (Ebf1) is a transcription factor involved in differentiation of various cell types.
• * Ebf1 is expressed in osteoblasts, and its global deletion increases bone formation.
• * The specific role of Ebf1 in osteoblasts has been unclear due to its expression in multiple tissues.

Purpose of the Study:

• * To determine the cell-autonomous and differentiation stage-specific roles of Ebf1 in osteoblasts.
• * To investigate the mechanism by which Ebf1 influences osteoblast differentiation.
• * To elucidate the dual role of Ebf1 in early and late stages of osteoblast differentiation and bone formation.

Main Methods:

• * In vitro studies using haploinsufficient Ebf1^+/- and overexpressed Ebf1 in mouse calvarial cells.
• * Identification of Ebf1 binding site in Osterix promoter using ChIP assay and reporter assays.
• * In vivo studies using conditional Ebf1 knockout mice (Ebf1^fl/fl crossed with Osx-Cre or hOC-Cre).
• * Analysis of bone phenotype using micro-computed tomography (μCT).

Main Results:

• * In vitro: Ebf1 haploinsufficiency impaired osteoblast differentiation; Ebf1 overexpression enhanced it, increasing Osterix (Osx) expression.
• * Ebf1 directly regulates Osterix expression by binding to its promoter.
• * In vivo: Deletion of Ebf1 in early osteoblasts (Ebf1_Osx^-/-) significantly increased bone volume and trabecular number.
• * Deletion of Ebf1 in late osteoblasts (Ebf1_hOC^-/-) did not result in a bone phenotype.

Conclusions:

• * Ebf1 promotes early osteoblast differentiation, partly through the induction of Osterix.
• * Ebf1 inhibits bone accrual in Osterix-expressing osteoblasts in vivo.
• * Ebf1 plays a dual role in osteoblast differentiation, promoting early stages and inhibiting later stages of bone formation.